Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

CancerJun 5, 2026
Executive summary of American Radium Society Appropriate Use Criteria for the treatment of locoregionally recurrent rectal cancer

Clinical Context

We think this might be relevant to the clinical guidance for Cornell Voltage Criteria (Left Ventricular Hypertrophy).

DiabetologiaMay 26, 2026
Clinical and psychological phenotypes of type 1 diabetes and disordered eating derived from a case vignette series: T1DE phenotypes

Clinical Context

We think this might be relevant to the clinical guidance for Cornell Voltage Criteria (Left Ventricular Hypertrophy).

DiabetologiaMay 22, 2026
Age-related patterns of cardiometabolic risk factors for complications in type 2 diabetes

Clinical Context

We think this might be relevant to the clinical guidance for Cornell Voltage Criteria (Left Ventricular Hypertrophy).

Cornell Voltage Criteria

Cornell LVH

Standard Voltage Analysis for LVH

mm
mm
Enhanced Sensitivity (Cornell Product)

The Cornell Criteria is highly reliable for specificity. However, if the sum is borderline, check for the "RaVL Criterion" (R in aVL > 11 mm) or signs of Left Atrial Enlargement.

Input EKG leads
to analyze LVH

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Primary Indications

ECG screening for left ventricular hypertrophy (LVH) – Non-invasive, widely available, low-cost initial test
Chronic hypertension monitoring – Assess target organ damage from long-standing or poorly controlled hypertension
Risk stratification in hypertensive patients – LVH by ECG predicts increased cardiovascular morbidity and mortality (2-4x higher risk of MI, stroke, heart failure, sudden cardiac death)
Sex-specific assessment – Superior sensitivity in women compared to Sokolow-Lyon (Cornell: 42% vs Sokolow-Lyon: 23% sensitivity at 95% specificity)
Screening for hypertrophic cardiomyopathy (HCM) – When combined with clinical suspicion and family history
Aortic stenosis severity assessment – LVH is an adaptive response to pressure overload; absence of LVH in severe AS suggests alternate diagnosis
Athlete vs pathology differentiation – Physiologic LVH in athletes (increased voltage with normal LV dimensions, no ST/T changes) vs pathologic LVH (with repolarization abnormalities)
Prognostic stratification post-MI – Regression of LVH with ACE inhibitors/ARBs predicts improved outcomes

Contraindications / Limitations

Left bundle branch block (LBBB) – Voltage criteria unreliable; rely on LBBB-specific LVH criteria (e.g., Sclarovsky-Birnbaum)
Ventricular paced rhythms – Artificial depolarization alters voltage distribution
Left anterior fascicular block (LAFB) – Alters frontal plane voltages; caution with interpretation
Poor ECG quality – Baseline wander, muscle artifact, improper lead placement invalidate measurements
Low voltage ECG – Obese patients, COPD, pericardial effusion, amyloidosis (Cornell will underdiagnose LVH)
Athletes with physiologic LVH – High voltage may be normal; requires clinical correlation (ST/T wave abnormalities suggest pathology)
NOT a substitute for echocardiography – ECG LVH criteria have modest sensitivity (30-50%) but high specificity (85-95%). Echo (LV mass index) is gold standard for LVH diagnosis.

Comparison of LVH ECG Criteria

CriterionFormulaThreshold (LVH Present)Sensitivity (Echo-proven LVH)SpecificityBest For
Cornell Voltage (original, 1991)RaVL + SV3Men: >20 mm Women: >28 mm40-50%90-95%Women (far better sensitivity than Sokolow-Lyon). General screening.
Cornell Product (1991)(RaVL + SV3) × QRS duration (ms)>2440 mm·ms45-55%90-95%Added accuracy when QRS is prolonged (intraventricular conduction delay)
Sokolow-Lyon (1949)SV1 + RV5 or RV6 (whichever larger)≥35 mm35-45%85-90%Men (historically derived from young men). Simpler to calculate.
Romhilt-Estes (1968)Point score system - Voltage criteria: 3 points - ST/T changes: 3 points - Left atrial enlargement: 3 points - Left axis deviation: 2 points - QRS duration >90ms: 1 point - Intrinsicoid deflection >50ms: 1 point≥5 points = definite LVH 4 points = probable LVH30-40%95-98%Highest specificity for autopsy-proven LVH (point score system)
Peguero-Lo Presti (2017)Deepest S wave in any lead (V1-V6) + SV4Men: >28 mm Women: >23 mm55-65%85-90%Obesity, COPD (where QRS voltages are generally lower)
Framingham (1990)SV1 + RV5/V6 or RaVL + SV3 (sex-specific continuous score)Sex-specific percentile-based (e.g., >95th percentile)Variable (depends on percentile)VariableResearch settings, not commonly used clinically

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the Sokolow-Lyon Voltage, LV Mass Index, Bazett Qtc or the Framingham Risk Score to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Primary Indications

ECG screening for left ventricular hypertrophy (LVH) – Non-invasive, widely available, low-cost initial test
Chronic hypertension monitoring – Assess target organ damage from long-standing or poorly controlled hypertension
Risk stratification in hypertensive patients – LVH by ECG predicts increased cardiovascular morbidity and mortality (2-4x higher risk of MI, stroke, heart failure, sudden cardiac death)
Sex-specific assessment – Superior sensitivity in women compared to Sokolow-Lyon (Cornell: 42% vs Sokolow-Lyon: 23% sensitivity at 95% specificity)
Screening for hypertrophic cardiomyopathy (HCM) – When combined with clinical suspicion and family history
Aortic stenosis severity assessment – LVH is an adaptive response to pressure overload; absence of LVH in severe AS suggests alternate diagnosis
Athlete vs pathology differentiation – Physiologic LVH in athletes (increased voltage with normal LV dimensions, no ST/T changes) vs pathologic LVH (with repolarization abnormalities)
Prognostic stratification post-MI – Regression of LVH with ACE inhibitors/ARBs predicts improved outcomes

Contraindications / Limitations

Left bundle branch block (LBBB) – Voltage criteria unreliable; rely on LBBB-specific LVH criteria (e.g., Sclarovsky-Birnbaum)
Ventricular paced rhythms – Artificial depolarization alters voltage distribution
Left anterior fascicular block (LAFB) – Alters frontal plane voltages; caution with interpretation
Poor ECG quality – Baseline wander, muscle artifact, improper lead placement invalidate measurements
Low voltage ECG – Obese patients, COPD, pericardial effusion, amyloidosis (Cornell will underdiagnose LVH)
Athletes with physiologic LVH – High voltage may be normal; requires clinical correlation (ST/T wave abnormalities suggest pathology)
NOT a substitute for echocardiography – ECG LVH criteria have modest sensitivity (30-50%) but high specificity (85-95%). Echo (LV mass index) is gold standard for LVH diagnosis.

Comparison of LVH ECG Criteria

CriterionFormulaThreshold (LVH Present)Sensitivity (Echo-proven LVH)SpecificityBest For
Cornell Voltage (original, 1991)RaVL + SV3Men: >20 mm Women: >28 mm40-50%90-95%Women (far better sensitivity than Sokolow-Lyon). General screening.
Cornell Product (1991)(RaVL + SV3) × QRS duration (ms)>2440 mm·ms45-55%90-95%Added accuracy when QRS is prolonged (intraventricular conduction delay)
Sokolow-Lyon (1949)SV1 + RV5 or RV6 (whichever larger)≥35 mm35-45%85-90%Men (historically derived from young men). Simpler to calculate.
Romhilt-Estes (1968)Point score system - Voltage criteria: 3 points - ST/T changes: 3 points - Left atrial enlargement: 3 points - Left axis deviation: 2 points - QRS duration >90ms: 1 point - Intrinsicoid deflection >50ms: 1 point≥5 points = definite LVH 4 points = probable LVH30-40%95-98%Highest specificity for autopsy-proven LVH (point score system)
Peguero-Lo Presti (2017)Deepest S wave in any lead (V1-V6) + SV4Men: >28 mm Women: >23 mm55-65%85-90%Obesity, COPD (where QRS voltages are generally lower)
Framingham (1990)SV1 + RV5/V6 or RaVL + SV3 (sex-specific continuous score)Sex-specific percentile-based (e.g., >95th percentile)Variable (depends on percentile)VariableResearch settings, not commonly used clinically

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the Sokolow-Lyon Voltage, LV Mass Index, Bazett Qtc or the Framingham Risk Score to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Cardiovascular Tools

Sokolow-Lyon Voltage
LV Mass Index
Wilkins Score
RVSP Calculator
Blood Pressure Percentiles
ADD-RS
Pulse Pressure
Troponin Delta Calculator
FFR
Cardiac Output Index
Cardiovascular CalculatorsCritical Care CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.